Merck News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

17.12.21	Merck: CHMP Adopts Positive Opinion For KEYTRUDA As Monotherapy For Adjuvant Treatment Of RCC (RTTNews)
14.12.21	Merck's HIV Trials Put On Clinical Hold, Vifor Gets A Suitor, VERU Scores FDA Nod... (RTTNews)
01.12.21	FDA Panel Narrowly Recommends Use Of Merck's Covid-19 Pill (RTTNews)
30.11.21	AstraZeneca's Lynparza Granted Priority Review In U.S. For High-risk Early Breast Cancer (RTTNews)
29.11.21	Merck : EU Approves KEYTRUDA Plus LENVIMA For Certain Types Of Endometrial Carcinoma, Advanced RCC (RTTNews)
29.11.21	Biotech Stocks Facing FDA Decision In December 2021 (RTTNews)
26.11.21	Merck: Interim Analysis, Additional Analyses Support Efficacy Of Molnupiravir (RTTNews)
11.11.21	Merck Initiates Phase 3 Study Of VERQUVO In Chronic Heart Failure And Reduced Ejection Fraction (RTTNews)
09.11.21	Merck And Ridgeback: U.S. Government To Buy 1.4 Mln Addl Courses Of Molnupiravir After FDA Approval (RTTNews)
28.10.21	Merck Q3 Results Top Estimates; Boosts FY21 Outlook - Quick Facts (RTTNews)
28.10.21	Merck & Co Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
27.10.21	Merck : Phase 2b Data Shows Islatravir - Doravirine Maintains Viral Suppression In HIV-1 Treatment (RTTNews)
27.10.21	Merck To Share License For Oral COVID-19 Antiviral Medicine With Developing Countries (RTTNews)
25.10.21	Xeris Biopharma In Collaboration With Merck On XeriJect; Stock Up 18% - Quick Facts (RTTNews)
25.10.21	Merck Announces Initiation Of Rolling Review By EMA For Molnupiravir For COVID-19 Treatment (RTTNews)
25.10.21	Merck : Positive Results From Phase 3 Trial Of Doravirine/Islatravir For HIV-1 Infection Treatment (RTTNews)
25.10.21	Evaxion Announces Collaboration With Merck & Co. To Evaluate EVX-01 With KEYTRUDA (RTTNews)
22.10.21	EU Approves Merck's Keytruda Plus Chemotherapy To Treat Triple-Negative Breast Cancer (RTTNews)
21.10.21	Merck Recalls About 22K Vials Of Antibiotic Injection Cubicin (RTTNews)
15.10.21	Merck, Eisai Receive Positive CHMP Opinions For Keytruda + Lenvima In Two Different Types Of Cancer (RTTNews)
11.10.21	Merck Seeks Emergency Nod In US For Molnupiravir To Treat Mild-to-moderate COVID-19 (RTTNews)
01.10.21	Merck Reports Positive Data From Molnupiravir Phase 3 Trial In Mild Or Moderate COVID-19 Patients (RTTNews)
30.09.21	Merck To Buy Acceleron Pharma For $11.5 Bln (RTTNews)
27.09.21	Merck: Phase 3 Trial With KEYTRUDA Meets Endpoint In Patients With Advanced Hepatocellular Carcinoma (RTTNews)
24.09.21	AstraZeneca: Lynparza PROpel Phase III Trial In 1st-line MCRPC Meets Primary Endpoint (RTTNews)
18.09.21	Merck's Keytruda Plus Chemotherapy Reduces Risk Of Death By One-Third In Metastatic Cervical Cancer (RTTNews)
18.09.21	Merck's Keytruda Shows Recurrence-free Survival In Resected High-Risk Stage II Melanoma (RTTNews)
17.09.21	Merck Gets Positive CHMP Opinion For Keytruda Plus Chemotherapy For Triple-Negative Breast Cancer (RTTNews)
16.09.21	France's BIOCORP, Merck Sign Partnership To Develop Specific Version Of Mallya Device (RTTNews)
09.09.21	Merck To Grow Group Sales Organically By More Than 6% Annually - Quick Facts (RTTNews)
07.09.21	Illumina Partners With Merck To Develop Tests For Use In Identifying Specific Cancer Mutations (RTTNews)
07.09.21	Merck: KEYTRUDA Regimen Approved In China For First-Line Treatment In Esophageal Cancer (RTTNews)
01.09.21	Merck, Ridgeback Initiate Phase 3 MOVe-AHEAD Study Of Molnupiravir For COVID-19 - Quick Facts (RTTNews)
26.08.21	Merck's Keytruda Gets Approvals For Recurrent Breast, Colorectal Cancer Treatments In Japan (RTTNews)
25.08.21	Merck: VAXNEUVANCE Meets Endpoints In Phase 3 Trial Evaluating Use In Infants (RTTNews)
18.08.21	Werewolf Collaborates With Merck On WTX-124 In Combination With KEYTRUDA - Quick Facts (RTTNews)
14.08.21	Merck Canada Initiates Rolling Submission to Health Canada for Molnupiravir, an Investigational Oral Therapeutic Agent for the Treatment of COVID-19 (PR Newswire)
14.08.21	Merck Canada Initiates Rolling Submission to Health Canada for Molnupiravir, an Investigational Oral Therapeutic Agent for the Treatment of COVID-19 (PR Newswire)
10.08.21	Merck: FDA To Review KEYTRUDA As Single Agent For Patients With MSI-H/dMMR Endometrial Carcinoma (RTTNews)
10.08.21	Merck: FDA Grants Priority Review To SBLA For KEYTRUDA As Adjuvant Immunotherapy In RCC (RTTNews)
29.07.21	Merck Q2 Profit Down; Cuts FY21 Outlook Below Market Estimates (RTTNews)
29.07.21	Merck & Co Inc. Q2 adjusted earnings of $1.31 per share (RTTNews)
27.07.21	FDA Approves Merck's KEYTRUDA To Treat High-Risk Early-Stage Triple-Negative Breast Cancer (RTTNews)
27.07.21	Merck : Phase 3 Trial On Metastatic Triple-Negative Breast Cancer Meets Primary Endpoint (RTTNews)
27.07.21	Biotech Stocks Facing FDA Decision In August 2021 (RTTNews)
22.07.21	Merck : FDA Approves Keytruda - Lenvima For Advanced Endometrial Carcinoma Treatment (RTTNews)
06.07.21	FDA OKs Expanded Indication For Merck's KEYTRUDA In Locally Advanced CSCC - Quick Facts (RTTNews)
29.06.21	Merck Animal Health Survey Reveals Pet Owners Need Advice Navigating Their Pets' Transition to Normalcy (PR Newswire)
29.06.21	EC Oks Merck's Keytruda Plus Chemotherapy For Treatment Of Certain Patients With Esophageal Cancer (RTTNews)
24.06.21	AZN : China Oks Lynparza To Treat BRCA-mutated Metastatic Castration-resistant Prostate Cancer (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

19.11.24		Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten
19.11.24		Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus
19.11.24		Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein
19.11.24		Gewinne in New York: NASDAQ 100 legt zu
19.11.24		Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell
19.11.24		Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer
19.11.24		Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

19.11.24

Schwacher Handel: Dow Jones beendet den Dienstagshandel mit Verlusten

19.11.24

Gute Stimmung in New York: NASDAQ 100 letztendlich im Plus

19.11.24

Schwacher Handel: Dow Jones legt am Dienstagnachmittag den Rückwärtsgang ein

19.11.24

Gewinne in New York: NASDAQ 100 legt zu

19.11.24

Dow Jones-Handel aktuell: So entwickelt sich der Dow Jones aktuell

19.11.24

Schwache Performance in Europa: Euro STOXX 50 zeigt sich zum Handelsende schwächer

19.11.24

Angespannte Stimmung in Europa: STOXX 50 verliert schlussendlich

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Givaudan	3’870.00	1.49 %	K V
Lonza Grp	513.60	1.14 %	K V
Swiss Re	125.25	0.20 %	K V
Holcim	88.46	0.11 %	K V
Kuehne+Nagel Int	210.40	0.00 %	K V
Logitech Intl	68.92	-1.20 %	K V
Part Grp Hldg	1’209.00	-1.47 %	K V
CieFinRichemont	118.90	-1.94 %	K V
Nestle	76.66	-1.94 %	K V
Sonova Hldg	300.40	-5.21 %	K V

Nachrichten zu Merck Co.

Aktien Top/Flop

Merck Peer Group Nachrichten

Meistgelesene Nachrichten